ZeroPhobia: Self-guided app-based Augmented Reality CBT treatment for fear of spider
- Conditions
- Specific phobia, arachnophobia, fear of spiders
- Registration Number
- NL-OMON27993
- Lead Sponsor
- Vrije Universiteit Amsterdam, Section of Clinical Psychology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
Arachnophobia: scoring above 59 on the Fear of Spiders Questionnaire (FSQ; Szymanski et al., 1995)
- between 18 - 64 years old
- have access to a compatible smart phone with internet/data access
- willing to participate in the research study and provide informed consent
Exclusion Criteria
- have insufficient knowledge of the Dutch language
- are under current treatment for specific phobia or psychotropic medication (unless on stable dosage for the previous 3 months and no changes planned during the study period).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the clinical effects of ZeroPhobia: whether (1) there is a reduction in arachnophobic symptoms as measured with the FSQ within-participants and between-participants (experimental vs control) post-test and whether (2) effects are sustainable at 3 and 12 month follow-up.
- Secondary Outcome Measures
Name Time Method To determine whether dropout rates are reduced with guided ARET, to determine the user-friendliness of ZeroPhobia, to determine whether usage intensity of augmented reality influences the effects of ZeroPhobia, to determine whether exposure or evaluating thoughts mediate anxiety outcomes, and to determine whether or not guided therapy is effective in reducing participant drop out rates.